PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,712 | -31.9% | 25,432 | -13.6% | 0.00% | – |
| Q2 2023 | $385,696 | -76.7% | 29,420 | -80.2% | 0.00% | – |
| Q1 2023 | $1,658,000 | +340351.7% | 148,218 | +156.4% | 0.00% | – |
| Q4 2022 | $487 | -99.9% | 57,814 | +76.5% | 0.00% | – |
| Q3 2022 | $545,000 | +16.7% | 32,763 | +3.2% | 0.00% | – |
| Q2 2022 | $467,000 | -29.8% | 31,737 | +18.4% | 0.00% | – |
| Q1 2022 | $665,000 | -59.8% | 26,810 | -48.0% | 0.00% | – |
| Q4 2021 | $1,655,000 | -71.1% | 51,604 | -67.6% | 0.00% | -100.0% |
| Q3 2021 | $5,728,000 | +960.7% | 159,193 | +1201.3% | 0.00% | – |
| Q2 2021 | $540,000 | -89.7% | 12,233 | -89.3% | 0.00% | -100.0% |
| Q1 2021 | $5,240,000 | +174.5% | 114,551 | +314.1% | 0.00% | – |
| Q4 2020 | $1,909,000 | – | 27,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |